Summary:
- The article discusses the legal troubles and controversies surrounding major pharmaceutical companies, including lawsuits, fines, and allegations of unethical practices.
- It highlights cases of pharmaceutical companies engaging in activities such as illegal marketing, concealing drug risks, price-fixing, and bribery.
- The article argues that these incidents raise concerns about the industry's integrity and the need for stricter regulation and oversight to ensure the safety and well-being of patients.